Parkside Financial Bank & Trust Has $56,000 Holdings in Evolent Health, Inc. (NYSE:EVH)

Parkside Financial Bank & Trust increased its holdings in shares of Evolent Health, Inc. (NYSE:EVH) by 90.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,957 shares of the technology company’s stock after purchasing an additional 2,358 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Evolent Health were worth $56,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Covestor Ltd lifted its position in Evolent Health by 138.1% during the 3rd quarter. Covestor Ltd now owns 1,424 shares of the technology company’s stock worth $40,000 after buying an additional 826 shares in the last quarter. R Squared Ltd bought a new stake in Evolent Health during the fourth quarter worth about $31,000. AlphaCentric Advisors LLC acquired a new position in Evolent Health during the fourth quarter valued at approximately $61,000. Point72 Asia Singapore Pte. Ltd. grew its stake in Evolent Health by 2,471.9% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,507 shares of the technology company’s stock valued at $184,000 after purchasing an additional 6,254 shares in the last quarter. Finally, US Bancorp DE increased its position in shares of Evolent Health by 180.3% during the 3rd quarter. US Bancorp DE now owns 6,579 shares of the technology company’s stock worth $186,000 after purchasing an additional 4,232 shares during the last quarter.

Evolent Health Price Performance

Evolent Health stock opened at $8.81 on Tuesday. The company has a market capitalization of $1.03 billion, a price-to-earnings ratio of -10.74 and a beta of 1.45. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.58. Evolent Health, Inc. has a 12 month low of $8.40 and a 12 month high of $35.00. The stock’s 50 day moving average is $10.56 and its 200-day moving average is $18.14.

Evolent Health (NYSE:EVH) last issued its quarterly earnings data on Thursday, February 20th. The technology company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.35). Evolent Health had a negative net margin of 2.41% and a positive return on equity of 5.73%. The firm had revenue of $646.54 million during the quarter, compared to analyst estimates of $650.92 million. Equities research analysts expect that Evolent Health, Inc. will post 0.08 EPS for the current year.

Analyst Ratings Changes

Several research firms have recently commented on EVH. UBS Group cut their price objective on Evolent Health from $27.00 to $14.00 and set a “buy” rating for the company in a report on Thursday, January 16th. BTIG Research cut their price target on shares of Evolent Health from $36.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Stephens lowered their price objective on shares of Evolent Health from $16.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 21st. Piper Sandler reiterated an “overweight” rating and issued a $16.00 target price (down from $17.00) on shares of Evolent Health in a research note on Friday, February 21st. Finally, Needham & Company LLC reissued a “buy” rating and set a $15.00 price target on shares of Evolent Health in a research report on Friday, February 21st. One research analyst has rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $17.79.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.